Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06430866
Status:
RECRUITING
Last Update Posted:
2024-05-28
First Post:
2024-03-15
Brief Title:
Pharmacokinetic Similarity Between ABP 234 and Keytruda Pembrolizumab
Sponsor:
Amgen
Organization:
Amgen